NOV Strangle Strategy
NOV (NOV Inc.), in the Energy sector, (Oil & Gas Equipment & Services industry), listed on NYSE.
NOV Inc. is a global leader in designing, manufacturing, and marketing essential systems, components, and products for the oil and gas drilling and production industries, as well as for industrial and renewable energy sectors worldwide. The company's operations are divided into three core segments: Wellbore Technologies, Completion & Production Solutions, and Rig Technologies. The Wellbore Technologies segment provides a range of offerings including solids control and waste management equipment, portable power generation units, drill and wired pipes, advanced drilling optimization and automation services, and comprehensive tubular inspection, repair, and coating services. This segment also supplies instrumentation, measuring and monitoring tools, downhole and fishing tools, steerable drilling technologies, and drill bits. The Completion & Production Solutions segment specializes in equipment and technologies for hydraulic fracture stimulation, encompassing downhole multistage fracturing tools, pressure pumping trucks, blenders, sanders, hydration and injection units, flowlines, and manifolds. They also offer coiled tubing units, wireline units and tools, and various connections and liner hangers.
NOV (NOV Inc.) trades in the Energy sector, specifically Oil & Gas Equipment & Services, with a market capitalization of approximately $7.45B, a trailing P/E of 78.41, a beta of 0.94 versus the broader market, a 52-week range of 12.02-21.55, average daily share volume of 4.3M, a public-listing history dating back to 1996, approximately 32K full-time employees. These structural characteristics shape how NOV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.94 places NOV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 78.41 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. NOV pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on NOV?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
NOV snapshot
As of August 14, 2026, spot at $21.27, ATM IV 29.90%, IV rank 6.88%, expected move 8.57%. The strangle on NOV below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.
Why this strangle structure on NOV specifically: NOV IV at 29.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a NOV strangle, with a market-implied 1-standard-deviation move of approximately 8.57% (roughly $1.82 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NOV expiries trade a higher absolute premium for lower per-day decay. Position sizing on NOV should anchor to the underlying notional of $21.27 per share and to the trader's directional view on NOV stock.
NOV strangle setup
The NOV strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NOV at $21.27 on that close, the first option leg uses a $22.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NOV chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NOV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $22.00 | $0.18 |
| Buy 1 | Put | $20.00 | $0.06 |
NOV strangle risk and reward
- Net Premium / Debit
- -$24.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$24.00
- Breakeven(s)
- $19.76, $22.24
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
NOV strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on NOV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$1,975.00 |
| $4.71 | -77.8% | +$1,504.82 |
| $9.41 | -55.7% | +$1,034.64 |
| $14.12 | -33.6% | +$564.46 |
| $18.82 | -11.5% | +$94.28 |
| $23.52 | +10.6% | +$127.90 |
| $28.22 | +32.7% | +$598.09 |
| $32.92 | +54.8% | +$1,068.27 |
| $37.62 | +76.9% | +$1,538.45 |
| $42.33 | +99.0% | +$2,008.63 |
When traders use strangle on NOV
Strangles on NOV are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NOV chain.
NOV thesis for this strangle
The market-implied 1-standard-deviation range for NOV extends from approximately $19.45 on the downside to $23.09 on the upside. A NOV long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current NOV IV rank near 6.88% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NOV at 29.90%. As a Energy name, NOV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NOV-specific events.
NOV strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NOV positions also carry Energy sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NOV alongside the broader basket even when NOV-specific fundamentals are unchanged. Always rebuild the position from current NOV chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on NOV?
- A strangle on NOV is the strangle strategy applied to NOV (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With NOV stock at $21.27 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed NOV chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are NOV strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the NOV strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 29.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$24.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a NOV strangle?
- The breakeven for the NOV strangle priced on this page is roughly $19.76 and $22.24 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The NOV market-implied 1-standard-deviation expected move in the same options snapshot is approximately 8.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on NOV?
- Strangles on NOV are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the NOV chain.
- How does current NOV implied volatility affect this strangle?
- NOV ATM IV is at 29.90% with IV rank near 6.88%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.